Estimates Revisions GlaxoSmithKline Pharmaceuticals Limited NSE India S.E.

Stocks

Market Closed - NSE India S.E. Other stock markets 07:05:07 2026-07-29 am EDT			5-day change	1st Jan Change
2,626.40 ^INR	-0.24%		+4.78%	+6.18%

May. 29	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
May. 13	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	ELI LILLY AND COMPANY
	JOHNSON & JOHNSON
	ABBVIE INC.
	ROCHE HOLDING AG
	NOVARTIS AG
	ASTRAZENECA PLC
	NOVO NORDISK A/S
	AMGEN INC.
	GILEAD SCIENCES, INC.
	Average
	Weighted average by Cap.